Deborah Cohen

797 total citations
42 papers, 518 citations indexed

About

Deborah Cohen is a scholar working on General Health Professions, Economics and Econometrics and Clinical Psychology. According to data from OpenAlex, Deborah Cohen has authored 42 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in General Health Professions, 6 papers in Economics and Econometrics and 5 papers in Clinical Psychology. Recurrent topics in Deborah Cohen's work include Health Services Management and Policy (5 papers), Pharmaceutical Economics and Policy (5 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Deborah Cohen is often cited by papers focused on Health Services Management and Policy (5 papers), Pharmaceutical Economics and Policy (5 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Deborah Cohen collaborates with scholars based in United States, United Kingdom and Sweden. Deborah Cohen's co-authors include Naomi J. Steiner, Stephen Cope, Sat Bir S. Khalsa, Dennis G. Karounos, J. Scott Bryson, Michael Fleming, Patricia Salt, Sharon Rae Jenkins, David K. Jones and Ariel Many and has published in prestigious journals such as Journal of Clinical Investigation, Annals of the New York Academy of Sciences and BMJ.

In The Last Decade

Deborah Cohen

37 papers receiving 472 citations

Peers

Deborah Cohen
Koushik Sinha Deb India
Servet Aker Türkiye
Kangxing Song China
Rebecca L. Flower Australia
Cynthia M. Khan United States
Yating Yang China
Yasmin Altwaijri Saudi Arabia
Isabella Moroz Canada
Sophie Epstein United Kingdom
Koushik Sinha Deb India
Deborah Cohen
Citations per year, relative to Deborah Cohen Deborah Cohen (= 1×) peers Koushik Sinha Deb

Countries citing papers authored by Deborah Cohen

Since Specialization
Citations

This map shows the geographic impact of Deborah Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Cohen more than expected).

Fields of papers citing papers by Deborah Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Cohen. The network helps show where Deborah Cohen may publish in the future.

Co-authorship network of co-authors of Deborah Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Cohen. A scholar is included among the top collaborators of Deborah Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Cohen. Deborah Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Abdel‐Meguid, S., et al.. (2025). Role of Nutrition in the Management of Chronic Liver Disease. Gastro Hep Advances. 4(5). 100613–100613.
3.
Cohen, Deborah. (2023). Money being paid for prescribing Wegovy in pilot studies is “over the top,” say critics. BMJ. 383. p2918–p2918. 2 indexed citations
4.
Cohen, Deborah, Shai Mulinari, & Piotr Ozierański. (2019). The whistleblowing drama behind Astellas’s suspension from the ABPI. BMJ. 366. l4353–l4353. 5 indexed citations
5.
Cohen, Deborah & C. Dyer. (2018). Off-label drugs directly compete with licensed drugs for same use, rules European court. BMJ. 360. k511–k511.
6.
Cohen, Deborah. (2018). CCGs win right to offer patients Avastin for wet AMD. BMJ. 362. k4035–k4035. 10 indexed citations
7.
Cohen, Deborah. (2018). Bayer and Novartis appeal ruling that Avastin for wet AMD is lawful. BMJ. 363. k4586–k4586. 1 indexed citations
8.
Cohen, Deborah. (2018). Doctors are cleared to prescribe cheaper drug for wet AMD. BMJ. 360. k344–k344. 2 indexed citations
9.
Cohen, Deborah. (2017). Opioid prescriptions in England doubled over 12 years, study shows. BMJ. 358(18). j4249–j4249. 5 indexed citations
10.
Cohen, Deborah. (2017). Roche asks WHO to remove Avastin from essential medicines list. BMJ. 356. j779–j779. 2 indexed citations
11.
Cohen, Deborah. (2017). CCGs face legal threat for offering off-label drug for wet AMD. BMJ. 359. j5021–j5021. 4 indexed citations
12.
Cohen, Deborah. (2017). All patients with metal-on-metal hip implants should undergo tests, says MHRA. BMJ. 358. j3246–j3246. 4 indexed citations
13.
Cohen, Deborah. (2017). Rules on reporting trials must be better enforced, say health integrity groups. BMJ. 359. j5786–j5786. 1 indexed citations
14.
Cohen, Deborah. (2017). Most drugs paid for by £1.27bn Cancer Drugs Fund had no “meaningful benefit”. BMJ. 357. j2097–j2097. 6 indexed citations
15.
Cohen, Deborah. (2014). Family secrets : the things we tried to hide. Penguin eBooks. 7 indexed citations
16.
Cohen, Deborah. (2013). The War No Image Could Capture.
17.
Khalsa, Sat Bir S., et al.. (2011). Evaluation of the Mental Health Benefits of Yoga in a Secondary School: A Preliminary Randomized Controlled Trial. The Journal of Behavioral Health Services & Research. 39(1). 80–90. 175 indexed citations
18.
Cohen, Deborah. (2010). Rosiglitazone: what went wrong?. BMJ. 341(sep06 2). c4848–c4848. 80 indexed citations
19.
Cohen, Deborah, et al.. (2004). Access all areas. BMJ. 329(7463). s78–s79. 1 indexed citations
20.
Karounos, Dennis G., J. Scott Bryson, & Deborah Cohen. (1997). Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice.. Journal of Clinical Investigation. 100(6). 1344–1348. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Koushik Sinha Deb Breakdown of academic impact, for papers by Servet Aker Breakdown of academic impact, for papers by Kangxing Song Breakdown of academic impact, for papers by Rebecca L. Flower Breakdown of academic impact, for papers by Cynthia M. Khan Breakdown of academic impact, for papers by Yating Yang Breakdown of academic impact, for papers by Yasmin Altwaijri Breakdown of academic impact, for papers by Isabella Moroz Breakdown of academic impact, for papers by Sophie Epstein
Rankless by CCL
2026